Delivery Order SPE2DB25D3306-SPE2DB25FUAWK

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $13,711.34 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the delivery of 18 mg Concerta ER tablets, a medication used to treat ADHD. The contract has a period of performance through July 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.53 delivery order contract is for the supply of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price pricing type and a completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $35,628.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 27 mg tablets, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a delivery order, with a firm fixed-price pricing type and an ultimate completion date of May 23, 2024. It is not designated as...
This federal contract award, valued at $1,732.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order, with a firm fixed-price pricing type, and has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a...
This federal contract award, valued at $3,317.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Concerta ER 27 MG Tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,775.49 firm fixed-price delivery order is for the supply of 36 mg CONCERTA ER tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order valued at $37,308.06, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.50 firm fixed-price delivery order is for Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of August 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,797.87 firm fixed price contract is for the supply of 100 tablets of Concerta ER 27 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through July 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $4,490.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUAWK
    Delivery Order

This federal contract award, valued at $3,357.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of Concerta ER 27 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition.

AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/16/25, 12:21 PM